These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28272224)

  • 21. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
    Youssef MY; Mohamed MA
    Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
    Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undifferentiated carcinoma of the endometrium: a review.
    Silva EG; Deavers MT; Malpica A
    Pathology; 2007 Feb; 39(1):134-8. PubMed ID: 17365829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers.
    Mills AM; Jenkins TM; Dibbern ME; Atkins KA; Ring KL
    Am J Surg Pathol; 2024 Jul; 48(7):790-802. PubMed ID: 38651612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
    Stewart CJ; Crook ML; Manso L
    Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas.
    Tessier-Cloutier B; Soslow RA; Stewart CJR; Köbel M; Lee CH
    Histopathology; 2018 Aug; 73(2):299-305. PubMed ID: 29671892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer.
    Tu L; Xu J; Wang M; Zhao WY; Zhang ZZ; Zhu CC; Tang DF; Zhang YQ; Wang DH; Zuo J; Cao H
    Tumour Biol; 2016 Jul; 37(7):8775-82. PubMed ID: 26743780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.
    Karasavvidou F; Barbanis S; Pappa D; Moutzouris G; Tzortzis V; Melekos MD; Koukoulis G
    Arch Pathol Lab Med; 2008 Dec; 132(12):1912-5. PubMed ID: 19061289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
    Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
    Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
    Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
    Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.
    Gun BD; Bahadir B; Bektas S; Barut F; Yurdakan G; Kandemir NO; Ozdamar SO
    Diagn Pathol; 2012 Jul; 7():80. PubMed ID: 22784357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Zou J; Yang H; Chen F; Zhao H; Lin P; Zhang J; Ye H; Wang L; Liu S
    Eur J Cancer Prev; 2010 Jan; 19(1):11-7. PubMed ID: 19741544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
    Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
    Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C; Manuel Lopes J; Oliva E
    Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.